Capital Asset Advisory Services’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,087	Closed	-$226K	–	318
2023 Q2	$226K	Sell	1,087 -200	-16%	-$39.8K	0.02%	301
2023 Q1	$260K	Sell	1,287 -63	-5%	-$14.3K	0.02%	287
2022 Q4	$321K	Sell	1,350 -1,709	-56%	-$373K	0.03%	258
2022 Q3	$602K	Sell	3,059 -1,322	-30%	-$285K	0.08%	146
2022 Q2	$937K	Buy	4,381 +82	+2%	+$20K	0.1%	137
2022 Q1	$1.22M	Buy	4,299 +663	+18%	+$204K	0.13%	105
2021 Q4	$1.37M	Buy	3,636 +203	+6%	+$78.9K	0.15%	96
2021 Q3	$1.42M	Buy	3,433 +32	+0.9%	+$13.3K	0.16%	87
2021 Q2	$1.26M	Buy	3,401 +355	+12%	+$119K	0.14%	100
2021 Q1	$883K	Buy	3,046 +390	+15%	+$108K	0.13%	144
2020 Q4	$664K	Buy	2,656 +268	+11%	+$63.8K	0.12%	150
2020 Q3	$541K	Sell	2,388 -187	-7%	-$38.8K	0.11%	147
2020 Q2	$541K	Buy	2,575 +42	+2%	+$6.7K	0.12%	157
2020 Q1	$408K	Buy	2,533 +364	+17%	+$54.6K	0.11%	157
2019 Q4	$376K	Buy	+2,169	New	+$300K	0.09%	221